Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503294 · ClinicalTrials.gov registry record
Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever
A clinical trial of Fever, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT01503294 is a study of Fever that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 596-participant average among 18 other Fever trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01503294, a study of Fever, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Assessment and evaluation of body temperature is an important sign of health and disease. Inferior thermometry increases the risk of morbidity and mortality, and increases health care cost by delaying the diagnosis and treatment of fever-related disease. The gold standard for measuring core body temperature is the pulmonary artery thermistor (PAT). The measurement of the PAT requires the insertion of the invasive pulmonary artery catheter, a high risk procedure. An innovative thermometry technology, the temporal artery thermometer (TAT), has been introduced into the clinical arena as a potential non-invasive proxy for the PAT. The TAT reduces the risk and cost of pulmonary artery catheter insertion by non-invasively measuring core blood temperature by measuring temperature over the skin of the temporal artery. Research to demonstrate the precision and accuracy of the TAT in normothermic patients has been published, but little to no data is available in those with temperatures greater than 100.4oF. The purpose of this study is to measure the precision and accuracy of 2standard of care temperature methods: the thermistor from the PAT, considered the gold standard, and the TAT as measured in those patients with a PAT temperature greater than 100.4oF.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01503294
The ClinicalTrials.gov registry entry for NCT01503294 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 596-participant average among 18 other Fever trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 0 interventions.
NCT01503294 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01503294 about?
NCT01503294 is a clinical study titled "Comparison of Temporal to Pulmonary Artery Temperature Measurement in Patients With Fever". Assessment and evaluation of body temperature is an important sign of health and disease. Inferior thermometry increases the risk of morbidity and mortality, and increases health care cost by delaying the diagnosis and treatment of fever-related disease. The gold standard for measuring core body tem...
What is the current status of trial NCT01503294?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-02. Estimated completion is 2014-06.
What conditions does trial NCT01503294 study?
This clinical trial studies the following conditions: Fever.
Who is sponsoring clinical trial NCT01503294?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01503294 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fever
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Remote Temperature Monitoring of Patients At Risk for Developing Fever
RECRUITING · NA
-
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
RECRUITING · NA
-
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
RECRUITING
-
Safety of RSV Preventive Monoclonal Antibody
RECRUITING · Phase 4
-
Tympanic Thermometer Study
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.